Shares of Moderna Inc. jumped 11.7% on Tuesday and added another 2.3% on Wednesday following news of the first reported human death linked to the circulating H5N1 strain.Key growth factors:Concerns about H5N1. Despite assurances from the Centers for Disease Control and Prevention (CDC) about the low risk of transmission of the virus among humans, increased attention to avian flu has increased interest in vaccine developers.The increase in respiratory infections. The CDC records an increase in ca... Více
RYCHLÉ ODKAZY